Bone Marrow Transplantation - Table of Contents alert Volume 51 Issue 10

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 51, Issue 10 (October 2016) In this issue Review Special Report Commentary Original Articles Letters to the Editor Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Marking 30 years of BMT publishing excellence - 1986 to 2016  Springer Nature is pleased to mark 30 years of Bone Marrow Transplantation journal publishing. We are commemorating the anniversary by giving everyone access to the 10 most cited BMT articles of all time and publishing an editorial by original editor Robert Gale that looks back over the journal's history.     Review Top Up-to-date tools for risk assessment before allogeneic hematopoietic cell transplantation M Elsawy and M L Sorror Bone Marrow Transplant 2016 51: 1283-1300; advance online publication, June 6, 2016; 10.1038/bmt.2016.141 Abstract | Full Text Special Report Top Disseminated cryptococcal infection in allogeneic stem cell transplant patients: a rare cause of acute kidney injury N Oliver, T Luong, A Tchakarov, M Abdelrahim, V E Mulanovich, D P Kontoyiannis, R Jones, P Kebriaei, J Samuels, W Glass and A Abudayyeh Bone Marrow Transplant 2016 51: 1301-1304; advance online publication, May 9, 2016; 10.1038/bmt.2016.120 Abstract | Full Text Commentary Top Could renal impairment be a positive predictor of outcome in autografts for myeloma? J Szer Bone Marrow Transplant 2016 51: 1305-1306; advance online publication, May 16, 2016; 10.1038/bmt.2016.138 Full Text Original Articles Top LYMPHOMA Busulfan-based reduced intensity conditioning regimens for haploidentical transplantation in relapsed/refractory Hodgkin lymphoma: Spanish multicenter experience J Gayoso, P Balsalobre, M J Pascual, C Castilla-Llorente, L López-Corral, M Kwon, D Serrano, J L Piñana, P Herrera, C Ferrá, C Pascual, I Heras, P Montesinos, A Zabalza, L Bento, A Figuera, I Buño and J L Díez-Martín on behalf of GETH (Spanish Group for Hematopoietic Transplantation) Bone Marrow Transplant 2016 51: 1307-1312; advance online publication, May 9, 2016; 10.1038/bmt.2016.115 Abstract | Full Text Brentuximab vedotin in combination with or without donor lymphocyte infusion for patients with Hodgkin lymphoma after allogeneic stem cell transplantation P Tsirigotis, I Danylesko, K Gkirkas, N Shem-Tov, R Yerushalmi, M Stamouli, A Avigdor, A Spyridonidis, J Gauthier, G Goldstein, J Apostolidis, M Mohty, A Shimoni and A Nagler Bone Marrow Transplant 2016 51: 1313-1317; advance online publication, May 16, 2016; 10.1038/bmt.2016.129 Abstract | Full Text PLASMA CELL DISORDERS Effect of severe hypoalbuminemia on toxicity of high-dose melphalan and autologous stem cell transplantation in patients with AL amyloidosis S Y Lee, R S Meehan, D C Seldin, J M Sloan, K Quillen, A Shelton, D Brauneis and V Sanchorawala Bone Marrow Transplant 2016 51: 1318-1322; advance online publication, May 16, 2016; 10.1038/bmt.2016.132 Abstract | Full Text APLASTIC ANEMIA Impact of pretransplant red cell transfusion on outcome after allogeneic stem cell transplantation in adult patients with severe aplastic anemia S-E Lee, S-A Yahng, B-S Cho, K-S Eom, Y-J Kim, H-J Kim, C-K Min, S Lee, S-G Cho, D-W Kim, W-S Min and J W Lee Bone Marrow Transplant 2016 51: 1323-1329; advance online publication, May 23, 2016; 10.1038/bmt.2016.140 Abstract | Full Text HEMATOPOIETIC CELL COLLECTION Bendamustine, etoposide and dexamethasone to mobilize peripheral blood hematopoietic stem cells for autologous transplantation in patients with multiple myeloma D J Green, W I Bensinger, L A Holmberg, T Gooley, B G Till, L E Budde, J M Pagel, S L Frayo, J E Roden, L Hedin, O W Press and A K Gopal Bone Marrow Transplant 2016 51: 1330-1336; advance online publication, May 23, 2016; 10.1038/bmt.2016.123 Abstract | Full Text CONDITIONING Melphalan 200 mg/m2 in patients with renal impairment is associated with increased short-term toxicity but improved response and longer treatment-free survival K Sweiss, S Patel, K Culos, A Oh, D Rondelli and P Patel Bone Marrow Transplant 2016 51: 1337-1341; advance online publication, May 16, 2016; 10.1038/bmt.2016.136 Abstract | Full Text TRANSPLANT TOXICITIES Identification of high-risk amino-acid substitutions in hematopoietic cell transplantation: a challenging task S R Marino, S M Lee, T A Binkowski, T Wang, M Haagenson, H-L Wang, M Maiers, S Spellman, K van Besien, S J Lee, T Karrison and A Artz Bone Marrow Transplant 2016 51: 1342-1349; advance online publication, May 23, 2016; 10.1038/bmt.2016.142 Abstract | Full Text GRAFT-VERSUS-HOST DISEASE Confounding factors affecting the National Institutes of Health (NIH) chronic Graft-Versus-Host Disease Organ-Specific Score and global severity S Z Aki, Y Inamoto, P A Carpenter, B E Storer, B M Sandmaier, S J Lee, P J Martin and M E D Flowers Bone Marrow Transplant 2016 51: 1350-1353; advance online publication, May 23, 2016; 10.1038/bmt.2016.131 Abstract | Full Text Haploidentical hematopoietic stem cell transplantation in children with high-risk hematologic malignancies: outcomes with two different strategies for GvHD prevention. Ex vivo T-cell depletion and post-transplant cyclophosphamide: 10 years of experience at a single center G Dufort, L Castillo, S Pisano, M Castiglioni, P Carolina, I Andrea, E Simon, S Zuccolo, M Schelotto, F Morosini, I Pereira, P Amarillo, A Silveira, L Guerrero, V Ferreira, A Tiscornia, R Mezzano, F Lemos, B Boggia, A Quarnetti, J Decaro and A Dabezies Bone Marrow Transplant 2016 51: 1354-1360; advance online publication, June 6, 2016; 10.1038/bmt.2016.161 Abstract | Full Text QOL AND PATIENTS' CARE The experience of survival following allogeneic haematopoietic stem cell transplantation in New South Wales, Australia G Gifford, N Gilroy, G Dyer, L Brice, M Kabir, M Greenwood, S Larsen, J Moore, D Gottlieb, M Hertzberg, J Kwan, G Huang, J Tan, L Brown, M Hogg, C Ward and I Kerridge Bone Marrow Transplant 2016 51: 1361-1368; advance online publication, May 23, 2016; 10.1038/bmt.2016.135 Abstract | Full Text Ovarian function after hematopoietic cell transplantation: a descriptive study following the use of GnRH agonists for myeloablative conditioning and observation only for reduced-intensity conditioning R Phelan, E Mann, C Napurski, T E DeFor, A Petryk, W P Miller, J E Wagner, M R Verneris and A R Smith Bone Marrow Transplant 2016 51: 1369-1375; advance online publication, June 6, 2016; 10.1038/bmt.2016.150 Abstract | Full Text Letters to the Editor Top Leukemia-free survival in myeloid leukemia, but not in lymphoid leukemia, is predicted by early CD4+ reconstitution following unrelated cord blood transplantation in children: a multicenter retrospective cohort analysis R Admiraal, R Chiesa, C A Lindemans, S Nierkens, M B Bierings, A B Versluijs, P Hiwarkar, J M Furtado Silva, P Veys and J J Boelens Bone Marrow Transplant 2016 51: 1376-1378; advance online publication, May 9, 2016; 10.1038/bmt.2016.116 Full Text CXCL10 can be detected non-invasively from the skin of children with acute skin GvHD P Khandelwal, K Smiley, A M Fieno, R A Grant and S M Davies Bone Marrow Transplant 2016 51: 1379-1381; advance online publication, May 9, 2016; 10.1038/bmt.2016.119 Full Text RSV infection without ribavirin treatment in pediatric hematopoietic stem cell transplantation J El-Bietar, A Nelson, G Wallace, C Dandoy, S Jodele, K C Myers, A Teusink, A Lane, S M Davies and L Danziger-Isakov Bone Marrow Transplant 2016 51: 1382-1384; advance online publication, May 16, 2016; 10.1038/bmt.2016.124 Full Text A unique case of tuberculosis dissemination presenting as cutaneous lesions in a post allogeneic stem cell transplant patient W Lam, A Viswabandya, S Hussain, H A Messner, F V Michelis, D D Kim, J H Lipton and U Deotare Bone Marrow Transplant 2016 51: 1385-1386; advance online publication, May 16, 2016; 10.1038/bmt.2016.137 Full Text Clinical relevance of galectin-1 in hematologic malignancies treated with non-myeloablative hemopoietic stem cell transplantation I Petruskevicius, M Ludvigsen, R Hjortebjerg, B S Sørensen, P Kamper, M Vase, L G Oestgaard, B Nielsen, B Honoré, M Bjerre, G A Rabinovich and F A d'Amore Bone Marrow Transplant 2016 51: 1387-1390; advance online publication, May 23, 2016; 10.1038/bmt.2016.127 Full Text Similar outcome of calreticulin type I and calreticulin type II mutations following RIC allogeneic haematopoietic stem cell transplantation for myelofibrosis M Christopeit, A Badbaran, T Zabelina, G Zeck, B Fehse, F Ayuk, C Wolschke and N Kröger Bone Marrow Transplant 2016 51: 1391-1393; advance online publication, May 23, 2016; 10.1038/bmt.2016.128 Full Text IV pentamidine for Pneumocystis jiroveci pneumonia prophylaxis in pediatric allogeneic stem cell transplant patients D A Curi, R E Duerst, C Badke, J Bell, S Chaudhury, M Kletzel, J Schneiderman, W T Tse, W J Muller and N Hijiya Bone Marrow Transplant 2016 51: 1394-1396; advance online publication, May 23, 2016; 10.1038/bmt.2016.133 Full Text A retrospective comparison of toxicity and initial efficacy of two autologous stem cell transplant conditioning regimens for relapsed lymphoma: LEAM and BEAM J Kothari, M Foley, K S Peggs, S Mackenzie, K Thomson, E Morris, K M Ardeshna, A E Virchis, D C Linch and J Lambert Bone Marrow Transplant 2016 51: 1397-1399; advance online publication, May 23, 2016; 10.1038/bmt.2016.134 Full Text All is not lost in accelerated phase/blast crisis and after tyrosine kinase inhibitors fail in chronic myeloid leukaemia: a retrospective study of allogeneic stem cell transplant outcomes in Australia and New Zealand P Kruger, J Cooney, I Nivison-Smith, A Dodds, P Bardy, D Ma, J Szer and S Durrant Bone Marrow Transplant 2016 51: 1400-1403; advance online publication, May 23, 2016; 10.1038/bmt.2016.143 Full Text The addition of ofatumumab to the conditioning regimen does not improve the outcome of patients with high-risk CLL undergoing reduced intensity allogeneic haematopoietic cell transplantation: a pilot trial from the GETH and GELLC (CLL4 trial) P Montesinos, M Cabrero, D Valcárcel, M Rovira, J A García-Marco, J Loscertales, C Moreno, R Duarte, M J Terol, N Villamor, P Abrisqueta, D Caballero, J Sanz and J Delgado Bone Marrow Transplant 2016 51: 1404-1407; advance online publication, May 23, 2016; 10.1038/bmt.2016.145 Full Text Reliability of immune receptor rearrangements as genetic markers for minimal residual disease monitoring V I Nazarov, A A Minervina, A Y Komkov, M V Pogorelyy, M A Maschan, Y V Olshanskaya, I V Zvyagin, D M Chudakov, Y B Lebedev and I Z Mamedov Bone Marrow Transplant 2016 51: 1408-1410; advance online publication, May 23, 2016; 10.1038/bmt.2016.148 Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Bone Marrow Transplantation. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.